Browse by UCL people
Group by: Type | Date
Number of items: 31.
2025
Coleman, Annabelle;
Touzé, Alexiane;
Farag, Mena;
Pengo, Marta;
Murphy, Michael J;
Hassan, Yara;
Thackeray, Olivia;
... Byrne, Lauren M; + view all
(2025)
Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases.
Journal of Neurology
, 272
(8)
, Article 501. 10.1007/s00415-025-13232-8.
|
 |
|
Estevez-Fraga, Carlos;
Sebenius, Isaac;
Hansen, Justine Y;
Haenisch, Benjamin;
Zeun, Paul;
Scahill, Rachael I;
Gregory, Sarah;
... McColgan, Peter; + view all
(2025)
Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease.
Nature Communications
, 16
, Article 5519. 10.1038/s41467-025-60556-0.
|
2024
|
Anderson, David G;
Ferreira-Correia, Aline;
Rodrigues, Filipe B;
Byrne, Lauren M;
Wild, Edward J;
Krause, Amanda;
(2024)
Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease.
Journal of Huntington's Disease
10.1177/18796397241300141.
(In press).
|
|
Bondulich, Marie K;
Phillips, Jemima;
Cañibano-Pico, María;
Nita, Iulia M;
Byrne, Lauren M;
Wild, Edward J;
Bates, Gillian P;
(2024)
Translatable plasma and CSF biomarkers for use in mouse models of Huntington’s disease.
Brain Communications
, 6
(1)
, Article fcae030. 10.1093/braincomms/fcae030.
(In press).
|
|
|
Caron, Nicholas S;
Byrne, Lauren M;
Lemarie, Fanny L;
Bone, Jeffrey N;
Aly, Amirah E-E;
Ko, Seunghyun;
Anderson, Christine;
... Hayden, Michael R; + view all
(2024)
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.
Translational Neurodegeneration
, 13
, Article 50. 10.1186/s40035-024-00443-8.
|
 |
|
Maiuri, Tamara;
Bazan, Carlos Barba;
Harding, Rachel J;
Begeja, Nola;
Kam, Tae-In;
Byrne, Lauren M;
Rodrigues, Filipe B;
... Truant, Ray; + view all
(2024)
Poly ADP-ribose signaling is dysregulated in Huntington disease.
PNAS (Proceedings of the National Academy of Sciences)
, 121
(40)
, Article e2318098121. 10.1073/pnas.2318098121.
|
|
|
Oosterloo, Mayke;
Touze, Alexiane;
Byrne, Lauren M;
Achenbach, Jannis;
Aksoy, Hande;
Coleman, Annabelle;
Lammert, Dawn;
... Pediatric Huntington Disease Working Group of the European Hunti; + view all
(2024)
Clinical Review of Juvenile Huntington’s Disease.
Journal of Huntington's Disease
10.3233/JHD-231523.
(In press).
|
|
2023
|
Coleman, Annabelle;
Touzé, Alexiane;
Farag, Mena;
Pengo, Marta;
Murphy, Michael J;
Hassan, Yara;
Thackeray, Olivia;
... Byrne, Lauren M; + view all
(2023)
Validation of remote collection and quantification of blood Neurofilament light in neurological diseases.
MedRxiv: Cold Spring Harbor, NY, USA.
|
2022
|
Byrne, Lauren M;
Schultz, Jordan L;
Rodrigues, Filipe B;
Plas, Ellen;
Langbehn, Douglas;
Nopoulos, Peggy C;
Wild, Edward J;
(2022)
Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children.
Movement Disorders
10.1002/mds.29027.
(In press).
|
|
Lipsmeier, Florian;
Simillion, Cedric;
Bamdadian, Atieh;
Tortelli, Rosanna;
Byrne, Lauren M;
Zhang, Yan-Ping;
Wolf, Detlef;
... Lindemann, Michael; + view all
(2022)
A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
Journal of Medical Internet Research
, 24
(6)
, Article e32997. 10.2196/32997.
|
2021
|
Brogueira Rodrigues, F;
Byrne, L;
Lowe, A;
Tortelli, R;
Heins, M;
Flik, G;
Johnson, E;
... Wild, E; + view all
(2021)
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington’s disease.
Journal of Neurochemistry
10.1111/jnc.15360.
(In press).
|
|
|
Caron, N;
Banos, R;
Yanick, C;
Aly, A;
Byrne, L;
Smith, E;
Xie, Y;
... Southwell, A; + view all
(2021)
Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
Journal of Neuroscience
, 41
(4)
pp. 780-796.
10.1523/JNEUROSCI.1865-20.2020.
|
|
|
Sanchez, II;
Nguyen, TB;
England, WE;
Lim, RG;
Vu, AQ;
Miramontes, R;
Byrne, LM;
... Thompson, LM; + view all
(2021)
Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization.
Journal of Clinical Investigation
, 131
(12)
, Article e140723. 10.1172/JCI140723.
|
|
Zhen-Yi, AO;
Byrne, L;
Brogueira Rodrigues, F;
Tortelli, R;
Johnson, E;
Foiani, M;
Arridge, M;
... Wild, E; + view all
(2021)
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease.
Scientific Reports
, 11
, Article 3481. 10.1038/s41598-021-83000-x.
|
|
2020
|
Brogueira Rodrigues, F;
Byrne, L;
Tortelli, R;
Johnson, E;
Wijeratne, P;
De Vita, E;
Ghazaleh, N;
... Wild, E; + view all
(2020)
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
Science Translational Medicine
, 12
(574)
10.1126/scitranslmed.abc2888.
|
|
|
Byrne, Lauren Mary;
(2020)
Development of biofluid biomarkers for Huntington’s disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Gregory, S;
Johnson, E;
Byrne, L;
Rodrigues, F;
Henderson, A;
Moss, J;
Thomas, D;
... Wild, E; + view all
(2020)
Characterising white matter in Huntington's disease.
Movement Disorders Clinical Practice
, 7
(1)
pp. 52-60.
10.1002/mdc3.12866.
|
|
|
Lowe, AJ;
Sjödin, S;
Rodrigues, FB;
Byrne, LM;
Blennow, K;
Tortelli, R;
Zetterberg, H;
(2020)
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
PLoS One
, 15
(8)
, Article e0233820. 10.1371/journal.pone.0233820.
|
|
|
Ou, ZYA;
Byrne, LM;
Rodrigues, FB;
Tortelli, R;
Johnson, EB;
Foiani, MS;
Arridge, M;
... Wild, EJ; + view all
(2020)
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease.
MedRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Scahill, RI;
Zeun, P;
Osborne-Crowley, K;
Johnson, EB;
Gregory, S;
Parker, C;
Lowe, J;
... Tabrizi, SJ; + view all
(2020)
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
The Lancet Neurology
, 19
(6)
pp. 502-512.
10.1016/S1474-4422(20)30143-5.
|
|
2019
|
Brogueira Rodrigues, FA;
Byrne, L;
De Vita, E;
Johnson, E;
Hobbs, N;
Thornton, J;
Scahill, R;
(2019)
Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.
European Journal of Neuroscience
10.1111/ejn.14356.
(In press).
|
2018
|
Byrne, LM;
Brogueira Rodrigues, F;
Johnson, E;
Wijeratne, P;
De Vita, E;
Alexander, D;
Palermo, G;
... Wild, E; + view all
(2018)
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease.
Science Translational Medicine
, 10
(458)
, Article eaat7108. 10.1126/scitranslmed.aat7108.
|
|
Byrne, LM;
Rodrigues, FB;
Johnson, EB;
Da Vita, E;
Blennow, K;
Scahill, RI;
Zetterberg, H;
... Wild, E; + view all
(2018)
Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease.
Scientific Reports
, Article 4260. 10.1038/s41598-018-21788-x.
|
|
|
Johnson, EB;
Byrne, LM;
Gregory, S;
Rodrigues, FB;
Blennow, K;
Durr, A;
Leavitt, BR;
... Wild, EJ; + view all
(2018)
Neurofilament light protein in blood predicts regional atrophy in Huntington disease.
Neurology
, 90
(8)
e717-e723.
10.1212/WNL.0000000000005005.
|
|
Rodrigues, FB;
Byrne, LM;
Wild, EJ;
(2018)
Biofluid Biomarkers in Huntington's Disease.
In: Precious, SV and Rosser, AE and Dunnett, SB, (eds.)
Huntington’s Disease.
(pp. 329-396).
Humana Press: New York, NY, USA.
|
2017
|
Byrne, LM;
Rodrigues, FB;
Blennow, K;
Durr, A;
Leavitt, BR;
Roos, RAC;
Scahill, RI;
... Wild, EJ; + view all
(2017)
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
The Lancet Neurology
, 16
(8)
pp. 601-609.
10.1016/S1474-4422(17)30124-2.
|
|
|
Fodale, V;
Boggio, A;
Daldin, M;
Cariulo, C;
Byrne, L;
Leavitt, B;
Wild, EJ;
... Bresciani, A; + view all
(2017)
Validation of ultrasensitive mutant huntingtin detection in human cerebrospinal fluid by single molecule counting immunoassay.
Journal of Huntington's Disease
, 6
(4)
pp. 349-361.
10.3233/JHD-170269.
|
2016
|
Byrne, LM;
Wild, EJ;
(2016)
Cerebrospinal Fluid Biomarkers for Huntington's Disease.
Journal of Huntington’s Disease
, 5
(1)
pp. 1-13.
10.3233/JHD-160196.
|
|
|
Rodrigues, FB;
Byrne, L;
McColgan, P;
Robertson, N;
Tabrizi, SJ;
Leavitt, BR;
Zetterberg, H;
(2016)
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.
Journal of Neurochemistry
, 139
(1)
pp. 22-25.
10.1111/jnc.13719.
|
|
Rodrigues, FB;
Byrne, LM;
McColgan, P;
Robertson, N;
Tabrizi, SJ;
Zetterberg, H;
Wild, EJ;
(2016)
Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease.
PLOS ONE
, 11
(9)
, Article e0163479. 10.1371/journal.pone.0163479.
|
2015
|
Wild, E;
Byrne, L;
Rodrigues, F;
(2015)
HD-CSF protocol.
(Studying cerebrospinal fluid to understand key CNS pathobiological targets in Huntington's disease
).
University College London (UCL): London, UK.
|
|
